Here is a link from the Carcinoid Cancer Foundation about 10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community
http://www.carcinoid.org/2014/12/18/10-highlights-of-the-year-2014-for-the-carcinoid-and-neuroendocrine-tumor-community/ Of the 10 highlights, see the first 4 that mention treatment breakthroughs with brief plain language descriptions:
1) Gallium 68 Clinical Studies
2) PRRT Clinical Trials
3) FDA Approves Lanreotide for Gastroenteropancreatic Neureoendocrine Tumors
4) Bringing the Promising Field of Immunotherapy to NETs

Using key search terms from this article you should be able to find more up-to-date information about each of these 4 areas.